4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000063
Director sold 7,791 shares at $27.55 ($214,642)
- Director acquired 15,934 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
FOUSE JACQUALYN A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,934 | 145,187 | D | ||
| 2024-04-10 | Sale : show line 2 in the form 10b5-1 | −7,791 | $27.55 | $214,642 | 137,396 | D |
| Open-market sales · 7,791 sh · avg $27.55 · $214,642 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-08 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −15,934 | 15,933 | D |
Loading xslF345X05/wk-form4_1712779426.xml…